Inhibitors of fibril formation and cytotoxicity of β-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element

Biochemical and Biophysical Research Communications

Volumn 290, Issue 1, 2002, Pages 121-124

  Watanabe, Ken Ichi ^a,b   Nakamura, Kazuhiko ^a   Akikusa, Shingo ^a,b   Okada, Tomoko ^a   Kodaka, Masato ^a   Okuno, Hiroaki ^a   Konakahara, Takeo ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; AMINOETHOXYETHOXYACETATE; AMYLOID BETA PROTEIN; ASPARTIC ACID; CONGO RED; LYSYLLEUCYLVALYLPHENYLALANYLPHENYLALANINE; PROTEIN DDX3; PROTEIN INHIBITOR; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; FIBER; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; SYNTHESIS;

EID: 0036289548     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6191     Document Type: Article

References (14)

1. History of amyloid fibril
2. Deposition of soluble amyloid-β onto amyloid templates: Identification of amyloid fibril extension inhibitors
3. Translating cell biology into therapeutic advances in Alzheimer’s disease
4. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro
5. Alzheimer’s amyloid fibrils: Structure and assembly
6. Arrest of beta-amyloid fibril formation by a pentapeptide ligand
7. Controlling amyloid beta-peptide fibril formation with protease-stable ligands
8. Identification of the molecular-interaction site of amyloid β peptide by using a fluorescence assay
9. Two simple methods for quantifying low-affinity dye-substrate binding
10. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson’s disease: Implications for pathogenesis and therapy
11. Modified-peptide inhibitors of amyloid β-peptide polymerization
12. Recognition sequence design for peptidyl modulators of β-amyloid aggregation and toxicity
13. Structure-function relationships for inhibitors of β-amyloid toxicity containing the recognition sequence KLVFF
14. Inhibition of β-amyloid(40) fibrillogenesis and disassembly of β-amyloid(40) fibrils by short β-amyloid congeners containing N-methyl amino acids at alternate residues